Eupraxia Pharmaceuticals Inc. (EPRX)

NCM – Real Time Price. Currency in USD

6.53

-0.17 (-2.54%)

Market open: Aug 12, 2026, 12:49 PM EDT

6.70

0.00 (0.00%)

Previous after-hours: Aug 11, 2026, 4:10 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

Cost of goods sold

-242K

-163K

-158K

-143K

Gross Profit

-242K

-163K

-158K

-143K

Operating expenses (excl. COGS)

-39M

-26M

-28M

-17M

Operating Income

-39M

-26M

-29M

-17M

Non-operating income, total

-155K

-977K

-252K

Pretax income

-39M

-25M

-30M

-18M

Equity in earnings

Taxes

-19K

-2K

68K

Non-controlling/minority interest

30K

230K

759K

485K

After tax other income/expense

Net income before discontinued operations

-39M

-24M

-29M

-17M

Discontinued operations

Net income

-39M

-24M

-29M

-17M

Dilution adjustment

Preferred dividends

Eupraxia Pharmaceuticals Inc. (EPRX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Eupraxia Pharmaceuticals Inc. (EPRX)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Eupraxia Pharmaceuticals Inc. (EPRX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Eupraxia Pharmaceuticals Inc. (EPRX)

Income Statement (Annual)

Income Statement (Annual)